Analysts Viewpoint
Mizuho gives a Buy recommendation for Terns Pharmaceuticals Inc (TERN)
Terns Pharmaceuticals Inc’s filing revealed that its Director Lu Hongbo acquired Company’s shares for reported $5.0 million on Sep 12
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.